Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example (Q37998398)

26 August 2017

title

Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example (English)

1 reference

26 August 2017

A Dalhoff

1

1 reference

26 August 2017

publication date

30 March 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

40

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

239-262

1 reference

Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fluoroquinolone-resistant typhoid, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Quinolone and cephalosporin resistance in enteric fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Surveillance of antimicrobial resistance--what, how and whither?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

World Wide Web resources on antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Endemic and epidemic lineages of Escherichia coli that cause urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum beta-lactamases in nursing homes in Belfast, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Clinical aspects and epidemiology of uncomplicated cystitis in women. German results of the ARESC Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Etiology and sensitivity of uropathogens identified in uncomplicated lower urinary tract infections in women (ARESC Study): implications on empiric therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

French results of the ARESC study: clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

High rates of quinolone resistance among urinary tract infections in the ED.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial resistance in uncomplicated urinary tract infections in 3 California EDs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

A clinical prediction rule for fluoroquinolone resistance in healthcare-acquired gram-negative urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

High prevalence of ST131 isolates producing CTX-M-15 and CTX-M-14 among extended-spectrum-beta-lactamase-producing Escherichia coli isolates from Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009–2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Within-household sharing of a fluoroquinolone-resistant Escherichia coli sequence type ST131 strain causing pediatric osteoarticular infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Risk factors for fluoroquinolone resistance in Enterococcus urinary tract infections in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Mechanisms of and Risk Factors for Fluoroquinolone Resistance in Clinical Enterococcus faecalis Isolates from Patients with Urinary Tract Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

The adherence of GPs to guidelines for the diagnosis and treatment of lower urinary tract infections in women is poor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Guidelines on uncomplicated urinary tract infections are difficult to follow: perceived barriers and suggested interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial management and appropriateness of treatment of urinary tract infection in general practice in Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Hospital fluoroquinolone prescription habits in northern France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial prescribing patterns for respiratory diseases including tuberculosis in Russia: a possible role in drug resistance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fluoroquinolones to treat uncomplicated acute cough in primary care: predictors for unjustified prescribing of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Respiratory tract infections in general practice: considerable differences in prescribing habits between general practitioners in Denmark and Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial-resistant invasive Escherichia coli, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Increasing resistance in commensal Escherichia coli, Bolivia and Peru.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Risk factors for fecal quinolone-resistant Escherichia coli in Mexican children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fluoroquinolone resistance in pediatric bloodstream infections because of Escherichia coli and Klebsiella species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Ciprofloxacin-resistant gram-negative bacilli in the fecal microflora of children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Risk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: community-based cross-sectional prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Uncomplicated urinary tract infection and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Incidence and epidemiology of levofloxacin resistance in Streptococcus pneumoniae: experience from a tertiary referral hospital in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

In vivo development of high-level fluoroquinolone resistance in Streptococcus pneumoniae in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fatal levofloxacin failure in treatment of a bacteremic patient infected with Streptococcus pneumoniae with a preexisting parC mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Ciprofloxacin treatment failure in a patient with resistant Streptococcus pneumoniae infection following prior ciprofloxacin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Quinolone resistance among pneumococci: therapeutic and diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Relationship between increased levofloxacin use and decreased susceptibility of Streptococcus pneumoniae in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Nonmolecular test for detection of low-level resistance to fluoroquinolones in Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Molecular characterization of increasing fluoroquinolone resistance in Streptococcus pneumoniae isolates in Canada, 1997 to 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial resistance among Streptococcus pneumoniae in the United States: have we begun to turn the corner on resistance to certain antimicrobial classes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Call for the international adoption of microbiological breakpoints for fluoroquinolones and Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fluoroquinolone and Macrolide Treatment Failure in Pneumococcal Pneumonia and Selection of Multidrug-Resistant Isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial resistance in respiratory tract Streptococcus pneumoniae isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Molecular characterization of emerging non-levofloxacin-susceptible pneumococci isolated from children in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antibiotic Use: The Crystal Ball for Predicting Antibiotic Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Evolutionary barriers to quinolone resistance in Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Relative fitness of fluoroquinolone-resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Quinolone-resistant Haemophilus influenzae in a long-term-care facility: nucleotide sequence characterization of alterations in the genes encoding DNA gyrase and DNA topoisomerase IV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Colonisation of fluoroquinolone-resistant Haemophilus influenzae among nursing home residents in southern Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emergence of fluoroquinolone-resistant Haemophilus influenzae strains among elderly patients but not among children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial activities of piperacillin-tazobactam against Haemophilus influenzae isolates, including beta-lactamase-negative ampicillin-resistant and beta-lactamase-positive amoxicillin-clavulanate-resistant isolates, and mutations in their quinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Decreased levofloxacin susceptibility in Haemophilus influenzae in children, Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Levofloxacin treatment failure in Haemophilus influenzae pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Detection of ciprofloxacin resistance in Haemophilus influenzae using nalidixic acid and BSAC methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Levofloxacin-resistant invasive Streptococcus pneumoniae in the United States: evidence for clonal spread and the impact of conjugate pneumococcal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Prevalence of first-step mutants among levofloxacin-susceptible invasive isolates of Streptococcus pneumoniae in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emerging resistance among bacterial pathogens in the intensive care unit--a European and North American Surveillance study (2000-2002)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial resistance in major pathogens of hospital-acquired pneumonia in Asian countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antibiotic sensitivity pattern of gram negative bacilli isolated from the lower respiratory tract of ventilated patients in the Intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Bactericidal and bacteriostatic activity of gemifloxacin against Acinetobacter spp. in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Surveillance for Antimicrobial Susceptibility among Clinical Isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from Hospitalized Patients in the United States, 1998 to 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Global challenge of multidrug-resistant Acinetobacter baumannii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. Medical Centers in 1992 and 1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

In vitro activity of several antimicrobial agents against 1003 isolates of Streptococcus pyogenes collected from Western Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Resistance to multiple fluoroquinolones in a clinical isolate of Streptococcus pyogenes: identification of gyrA and parC and specification of point mutations associated with resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Characterization of fluoroquinolone-resistant beta-hemolytic Streptococcus spp. isolated in North America and Europe including the first report of fluoroquinolone-resistant Streptococcus dysgalactiae subspecies equisimilis: report from the SENTRY An

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fluoroquinolone resistance in Streptococcus pyogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

High-level fluoroquinolone resistance in a clinical Streptoccoccus pyogenes isolate in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Factors influencing methicillin resistance in staphylococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Methicillin-resistant Staphylococcus aureus in a teaching hospital: investigation of nosocomial transmission using a matched case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fluoroquinolone resistance among Gram-positive cocci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Community-acquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Are the new quinolones appropriate treatment for community-acquired methicillin-resistant Staphylococcus aureus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emerging infections with community-associated methicillin-resistant Staphylococcus aureus in outpatients at an Army Community Hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antibacterial effects of moxifloxacin and levofloxacin simulating epithelial lining fluid concentrations against community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

High frequencies of clindamycin and tetracycline resistance in methicillin-resistant Staphylococcus aureus pulsed-field type USA300 isolates collected at a Boston ambulatory health center

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Virulence characteristics of community-associated Staphylococcus aureus and in vitro activities of moxifloxacin alone and in combination against community-associated and healthcare-associated meticillin-resistant and -susceptible S. aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Grou

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Diabetic foot infections. Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

In vitro activities of moxifloxacin against 900 aerobic and anaerobic surgical isolates from patients with intra-abdominal and diabetic foot infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emergence of fluoroquinolone resistance among Bacteroides species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Strain typing and antimicrobial resistance of fluoroquinolone-resistant Neisseria gonorrhoeae causing a California infection outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Analysis of trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Australia, 1997 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Effect of antimicrobial agents on the ecological balance of human microflora

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Shifting the balance: antibiotic effects on host–microbiota mutualism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Long-term impacts of antibiotic exposure on the human intestinal microbiota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Mechanisms and spread of fluoroquinolone resistance in Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Ciprofloxacin dosage and emergence of resistance in human commensal bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Independent behavior of commensal flora for carriage of fluoroquinolone-resistant bacteria in patients at admission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Interspecies recombination contributes minimally to fluoroquinolone resistance in Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Interspecies recombination in type II topoisomerase genes is not a major cause of fluoroquinolone resistance in invasive Streptococcus pneumoniae isolates in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

In vitro exchange of fluoroquinolone resistance determinants between Streptococcus pneumoniae and viridans streptococci and genomic organization of the parE-parC region in S. mitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Molecular evolution perspectives on intraspecific lateral DNA transfer of topoisomerase and gyrase loci in Streptococcus pneumoniae, with implications for fluoroquinolone resistance development and spread

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Interspecies recombination occurs frequently in quinolone resistance-determining regions of clinical isolates of Streptococcus pyogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fluoroquinolone resistance in Streptococcus dysgalactiae subsp. equisimilis and evidence for a shared global gene pool with Streptococcus pyogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emerging resistance in Neisseria meningitidis and Neisseria gonorrhoeae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Ciprofloxacin-resistant Neisseria meningitidis, Delhi, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emergence of Neisseria meningitidis with decreased susceptibility to ciprofloxacin in Argentina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Invasive Neisseria meningitidis with decreased susceptibility to fluoroquinolones in South Africa, 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Neisseria meningitidis showing decreased susceptibility to ciprofloxacin: first report in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Fluoroquinolone resistance in Neisseria meningitidis in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

An invasive isolate of Neisseria meningitidis showing decreased susceptibility to quinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

In vitro assessment of the further potential for development of fluoroquinolone resistance in Neisseria meningitidis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Ciprofloxacin resistance in Neisseria meningitidis, France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Serogroup A Neisseria meningitidis with reduced susceptibility to ciprofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Nalidixic acid disk for laboratory detection of ciprofloxacin resistance in Neisseria meningitidis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Population biology of the human restricted pathogen, Streptococcus pyogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Stability of fluoroquinolone resistance in Streptococcus pneumoniae clinical isolates and laboratory-derived mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

The stability of grlA, grlB, gyrA, gyrB and norA mutations and MIC values of five fluoroquinolones in three different clonal populations of methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Emerging antibiotic resistance in urinary tract pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Hospital-wide modification of fluoroquinolone policy and meticillin-resistant Staphylococcus aureus rates: a 10-year interrupted time-series analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Plasmid-mediated quinolone resistance: a multifaceted threat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

In vitro activity of the aerosolized agents colistin and tobramycin and five intravenous agents against Pseudomonas aeruginosa isolated from cystic fibrosis patients in southwestern Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Ciprofloxacin susceptibility of Pseudomonas aeruginosa isolates from keratitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Stratification of cumulative antibiograms in hospitals for hospital unit, specimen type, isolate sequence and duration of hospital stay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Laboratory testing policies and their effects on routine surveillance of community antimicrobial resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

When do general practitioners request urine specimens for microbiology analysis? The applicability of antibiotic resistance surveillance based on routinely collected data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Increased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antibiotic sensitivity of isolates from nosocomial and community-acquired urinary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Antibiotic susceptibility patterns of community- and hospital-acquired Staphylococcus aureus and Escherichia coli in Estonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Secular trend and risk factors for antimicrobial resistance in Escherichia coli isolates in Switzerland 1997-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Variation by specialty in the treatment of urinary tract infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

General practitioner practices in requesting laboratory tests for patients with gastroenteritis in the Netherlands, 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Report of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Surveillance Subgroup.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Changes in Escherichia coli resistance patterns during and after antibiotic therapy: a longitudinal study among outpatients in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Consumer survey on microbiology reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Low prevalence of fluoroquinolone resistant strains and resistance precursor strains in Streptococcus pneumoniae from patients with community-acquired pneumonia despite high fluoroquinolone usage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Klebsiella pneumoniae ESBL producers responsible for severe UTIs in a renal transplant unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S15010-012-0257-2

Irrational Prescribing in South Asia: A Case of Fluoroquinolone-associated Phototoxicity

21 January 2018

1 reference

12 December 2020

The contribution of in vitro bacteriologic experiments.

1 reference

12 December 2020

Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay

1 reference

12 December 2020

Analysis, power and design of antimicrobial resistance surveillance studies, taking account of inter-centre variation and turnover

1 reference

12 December 2020

Effect of new antimicrobial agents on the ecological balance of human microflora

1 reference

12 December 2020

Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae

1 reference

12 December 2020

Sexually transmitted diseases treatment guidelines, 2010

1 reference

12 December 2020

Fluoroquinolone-resistant pneumococci: maybe resistance isn't futile?

1 reference

12 December 2020

Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics

1 reference

12 December 2020

In vitro antibacterial activity and pharmacodynamics of new quinolones

1 reference

12 December 2020

2009 European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea in adults

1 reference

12 December 2020

Insights into a multidrug resistant Escherichia coli pathogen of the globally disseminated ST131 lineage: genome analysis and virulence mechanisms

1 reference

12 December 2020

ESBL genotypes in fluoroquinolone-resistant and fluoroquinolone-susceptible ESBL-producing Escherichia coli urinary isolates in Manitoba

1 reference

12 December 2020

A case series of macrolide treatment failures in community acquired pneumonia

1 reference

12 December 2020

Neisseria meningitidis with reduced susceptibility to quinolones in Singapore

1 reference

12 December 2020

Community-acquired methicillin-resistant Staphylococcus aureus: what do we need to know?

1 reference

12 December 2020

Ciprofloxacin for eradication of methicillin-resistant Staphylococcus aureus colonization

1 reference

12 December 2020

Clinical relevance of laboratory-reported antibiotic resistance in acute uncomplicated urinary tract infection in primary care

1 reference

12 December 2020

Global fluoroquinolone resistance epidemiology and implictions for clinical use.

1 reference

12 December 2020

Annual report of the Australian Meningococcal Surveillance Programme, 2009.

1 reference

12 December 2020

Emergence and dissemination of quinolone-resistant Escherichia coli in the community

1 reference

12 December 2020

Drug utilization in general practice: prescribing habits of National Formulary drugs by GPs of Emilia Romagna (Italy) in 1988 and 1989

1 reference

12 December 2020

Moraxella catarrhalis as a respiratory pathogen

1 reference

12 December 2020

Diverse Phenotypic and Genotypic Characterization Among ClinicalKlebsiella pneumoniaeandEscherichia coliIsolates Carrying Plasmid-Mediated Quinolone Resistance Determinants

1 reference

12 December 2020

Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, Spain

1 reference

12 December 2020

UK national guideline for the management of gonorrhoea in adults, 2011

1 reference

12 December 2020

In vitro activities of quinolones

1 reference

12 December 2020

In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010

1 reference

12 December 2020

Non-susceptibility trends and serotype distributions among Streptococcus pneumoniae from community-acquired respiratory tract infections and from bacteraemias in the UK and Ireland, 1999 to 2007.

1 reference

12 December 2020

Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections.

1 reference

12 December 2020

An overview of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR).

1 reference

12 December 2020

The changing pattern of antimicrobial resistance within 42,033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999-2009

1 reference

12 December 2020

Fluoroquinolone-resistant Moraxella catarrhalis in a patient with pneumonia: report from the SENTRY Antimicrobial Surveillance Program (1998)

1 reference

12 December 2020

Emergence of fluoroquinolone-resistant Neisseria meningitidis--Minnesota and North Dakota, 2007-2008.

1 reference

12 December 2020

“Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy

1 reference

12 December 2020

Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009.

1 reference

12 December 2020

A blood isolate of Neisseria meningitidis showing reduced susceptibility to quinolones in Hong Kong

1 reference

12 December 2020

Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin.

1 reference

12 December 2020

In vitro activity of levofloxacin against a selected group of anaerobic bacteria isolated from skin and soft tissue infections.

1 reference

12 December 2020

Clinical value of microbiological investigations in general practice

1 reference

12 December 2020

Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment

1 reference

12 December 2020

Prescribing habits of general practitioners in choosing an empirical antibiotic regimen for lower respiratory tract infections in adults in Sicily

1 reference

12 December 2020

Dispensing of antibiotics without prescription in Greece, 2008: another link in the antibiotic resistance chain

1 reference

12 December 2020

Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections

1 reference

12 December 2020

Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe.

1 reference

12 December 2020

Use of microbiology reports by physicians in prescribing antimicrobial agents

1 reference

12 December 2020

10.1007/S15010-012-0257-2

Identifiers

DOI

1 reference

26 August 2017

1 reference